Michael S McGrath
10PUBLICATIONS
6CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Dec 30, 2025
Quantitative Measures of Time to Loss of 15% Vital Capacity and Survival Extension in Slowly Progressive Amyotrophic Lateral Sclerosis (ALS) Patients Treated with the Immune Regulator NP001 Suggests an Immunopathogenic Subset of ALS.Namita A Goyal, Jinsy A Andrews, Björn E Oskarsson
|May 14, 2025
Respiratory Function Improvement and Lifespan Extension Following Immunotherapy with NP001 Support the Concept That Amyotrophic Lateral Sclerosis (ALS) Is an Immuno-Neurologic Disease.Rongzhen Zhang, Ari Azhir, Michael S McGrath
|Oct 26, 2024
Systemic Innate Immune System Restoration as a Therapeutic Approach for Neurodegenerative Disease: Effects of NP001 on Amyotrophic Lateral Sclerosis (ALS) Progression.Michael S McGrath, Rongzhen Zhang, Paige M Bracci
|Oct 16, 2024
Utility of an Archival Dried Blood Spot (DBS) Collection from HIV-Infected Individuals with and without Cancer in a Resource-Limited Setting.Rongzhen Zhang, Paige M Bracci, Alan Leong
|Apr 13, 2023
Regulation of the Innate Immune System as a Therapeutic Approach to Supporting Respiratory Function in ALS.Michael S McGrath, Rongzhen Zhang, Paige M Bracci
|Dec 23, 2022
The Persistence of HIV Diversity, Transcription, and Nef Protein in Kaposi's Sarcoma Tumors during Antiretroviral Therapy.David J Nolan, Rebecca Rose, Rongzhen Zhang
Pageof 2
